Navigation Links
Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Oral Picoplatin Demonstrating Bioavailability
Date:4/21/2009

- Pharmacologic Data Presented at American Association for Cancer Research's 100th Annual Meeting 2009 -

SOUTH SAN FRANCISCO, Calif. and DENVER, April 21 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced the presentation of final data from a Phase 1 clinical study of an oral formulation of picoplatin in patients with solid tumors. Results showed that the bioavailability of oral picoplatin is nearly 100 percent at doses of 50 mg and 100 mg, indicating sufficient bioavailability to support further clinical development.

Picoplatin, the Company's lead product candidate, is a new generation platinum chemotherapy agent in clinical development to treat a variety of solid tumors. It was designed to overcome platinum resistance of the tumor, which remains a medical challenge for oncologists and patients, whose therapeutic options become limited. Poniard is currently evaluating an intravenous formulation of picoplatin in a pivotal Phase 3 trial in patients with small cell lung cancer (SCLC) and in Phase 2 trials in metastatic colorectal cancer (CRC) and metastatic castration-resistant prostate cancer (CRPC).

"The results of the Phase 1 trial demonstrating the oral bioavailability of picoplatin support the continued development of an oral formulation for multiple tumor indications," said Robert De Jager, M.D., chief medical officer of Poniard. "We believe that oral picoplatin may offer opportunities for studies in new indications and in combinations with other chemotherapeutics or with radiation therapy. The administration options for oral picoplatin may provide more convenience to cancer patients and could enable the potential of multiple combination therapies."

The picoplatin data were presented today in a poster ses
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Poniard Pharmaceuticals Announces Upcoming Conference Participation
2. Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update
3. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
4. Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin
5. Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
6. Poniard Pharmaceuticals Receives Going Concern Qualification
7. Poniard Pharmaceuticals to Present at Needham & Companys Cancer Therapeutics: Today & Tomorrow Conference
8. Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
9. Poniard Announces Publication of Results of Picoplatin Phase 2 Study in Journal of Clinical Oncology
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... September 01, 2014 Building on the ... American Sleep and Breathing Academy (ASBA) has ... Conference for Healthcare Professionals. The event will be taking ... April 10th and 11th. This years’ event promises to ... the ASBA. , In recent years, Pro ...
(Date:9/1/2014)... mental health and substance use problems in adolescents ... the consequences of cyberbullying and also be beneficial ... Elgar, Ph.D., of McGill University, Montreal, Canada, and ... has experienced recent online bullying and cyberbullying, like ... health problems in teens as well as the ...
(Date:9/1/2014)... Sept. 1, 2014 (HealthDay News) -- You may be able ... unhealthy ones, new research suggests. The study included eight ... designed weight-loss program meant to change how people react to ... of five overweight and obese people who weren,t in the ... start of the study and again six months later. The ...
(Date:9/1/2014)... Currently, scientists continue to face fundamental ... disease (AD), which reflects their poor understanding of ... of the disease, especially in its early stages, ... In 2014, after decades that have witnessed ... medicine world, there are still no disease-modifying therapies ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 "Women struggle ... These hormonal daily changes begin as early as 15, ... their lives negotiating the ups and downs of hormone ... thin or even healthy sizes seems to rage against ... As a woman in her 40's begin to face ...
Breaking Medicine News(10 mins):Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 2Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 3Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 4Health News:Family dinners good for teens' mental health, could protect from cyberbullying 2Health News:Family dinners good for teens' mental health, could protect from cyberbullying 3Health News:Train Your Brain to Choose Fruit Salad Over French Fries 2Health News:Early Stage Minimally Invasive Candidate AD Biomarkers Reviewed in New Study by Biopharm Reports Available at MarketPublishers.com 2Health News:Early Stage Minimally Invasive Candidate AD Biomarkers Reviewed in New Study by Biopharm Reports Available at MarketPublishers.com 3Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 2Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 3
... can cause liver or stomach illness in certain ... News) -- Many over-the-counter painkillers and fever reducers ... potential danger of liver damage and stomach bleeding, ... have to include these warnings on all their ...
... DURECT Corporation,s (Nasdaq: DRRX ) first quarter 2009 ... the conference call that will be broadcast live over the ... Time (1:30 pm Pacific Time).A live audio webcast of the ... http://www.durect.com and clicking "Investor Relations." ...
... Encryption business continues to drive performance for CompanyDALLAS, April ... ), the leader in hosted services for email encryption ... first quarter ended March 31, 2009. ZixCorp recorded ... net loss of $1.5 million for the quarter, or ...
... Specter (?-Penn) switched political parties from Republican to Democrat. Tom ... arm of Family Research Council, had this to say:"Senator Specter,s ... old saying, ,if it looks like a donkey, quacks like ... is probably a donkey., This holds true for Senator ...
... is a risk for a catastrophic pandemic -FLEMINGTON, N.J., ... physicians revealed that a majority of physicians (63%) reported ... Swine Flu will result in a worldwide catastrophic pandemic.(Logo: ... was conducted by HCD Research and the Muhlenberg ...
... Aid IllinoisCHICAGO, April 28 The Third Annual ... continuing impact that AmeriCorps volunteers are having across ... volunteers serving in Illinois this year, assisting at-risk ... for low-income families, and assisting nonprofits in volunteer ...
Cached Medicine News:Health News:FDA Adds New Label Warnings to Over-the-Counter Painkillers 2Health News:Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results 2Health News:Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results 3Health News:Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results 4Health News:Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results 5Health News:Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results 6Health News:Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results 7Health News:Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results 8Health News:Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results 9Health News:Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results 10Health News:Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results 11Health News:Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results 12Health News:Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results 13Health News:Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results 14Health News:Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results 15Health News:Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results 16Health News:Zix Corporation Reports Highest Revenue Quarter as Company Announces First Quarter 2009 Financial Results 17Health News:Swine Flu Outbreaks Cause Concern among U.S. Physicians 2Health News:Swine Flu Outbreaks Cause Concern among U.S. Physicians 3Health News:Third Annual AmeriCorps Week 2Health News:Third Annual AmeriCorps Week 3
(Date:8/29/2014)... -- Thoratec Corporation (NASDAQ: THOR ), a ... save, support and restore failing hearts, said today it ... Healthcare Conference on Wednesday, September 10. ... will provide an update on the company, beginning at ... Time).   A webcast of the presentation ...
(Date:8/29/2014)... Research and Markets has announced the addition ... report to their offering. Benefiting ... for medical expenses, the Chinese orthopedic instrument market demand ... CAGR of 19.2% during 2009-2013. Trauma products, spine products ... instruments in China , of which ...
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 Research ... CNS Disorders Drug Pipeline Insight 2014" report to their ... market in US is one of the largest segments of ... an alarming rate, while the available therapies were unable to ... growth in the market for CNS disorder, especially over the ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2US CNS Disorders Drug Pipeline Insight 2014 2
... MedShape Solutions, Inc, a developer of shape memory orthopedic ... Blair and Tom Hills to the Board of Directors effective ... of experience in the healthcare field, including serving as the ... as the Non-executive Chairman of DJO, Inc., (formerly NYSE-listed sports ...
... Inc. (Pink Sheets: SNDY) is pleased to announce that ... demonstrated at the 95th Annual American College of Surgeons ... During the Breast Ductoscopy for the General Surgeon course, ... hands-on skill stations that will provide the core knowledge ...
Cached Medicine Technology:MedShape Solutions, Inc. Appoints Jack Blair and Tom Hills to Board of Directors; Announces Additions to Management Team 2Solos Endoscopy, Inc.'s MammoView(TM) Product Line to be Demonstrated at the 95th Annual American College of Surgeons Clinical Congress 2
Plasma Control Level 1 - 1 ml...
The Mini Vidas is a compact version of the Vidas system with a built-in computer, keyboard and printer. Two independent sections each accept six tests and can process up to 12 samples simultaneously....
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: